Search results
Results From The WOW.Com Content Network
The company operated at a loss for 2011 and 2012, and made money for the first time in 2013 on the basis of a single contract signed by one of its subsidiaries. [1] In 2013, MMI and CannaVEST, an exchange-traded fund, each invested in a company called Kannalife Sciences Inc.
Was the Department of Health Division of Medical Marijuana and Integrative Therapy until October 1, 2020; [6] medical cannabis only – there is no regulatory agency for other use. [a] Puerto Rico Medical Cannabis Regulatory Board (a division of the Puerto Rico Department of Health). The Board was created in 2017 under the MEDICINAL Act of 2017 ...
Aphria Inc., headquartered in Leamington, Ontario, was an international producer and distributor of medicinal and recreational cannabis. The company operated through retail and wholesale channels in Canada and internationally. Aphria was a main distributor of medical cannabis to Germany and had operations in 10 additional countries outside of ...
Medical Marijuana, Inc. (OTC: MJNA), the first publicly-traded cannabis company to launch cannabis-derived nutraceutical products, brands, and supply chains announced that its subsidiary HempMeds ...
MedMen Enterprises was a United States-based cannabis company. At its peak, it had operations in California, Nevada, Arizona, Florida, Illinois, New York, and Massachusetts. [2] [3] MedMen owns and operates 29 retail stores and 6 cultivation facilities and is currently licensed to expand its footprint to 65 retail locations. [4]
"Among medical-only states, Florida continued its double-digit growth, adding an astonishing 324,400 medical marijuana patients in 2022 — bringing the state’s registered total to 781,000 ...
The Department of Cannabis Control (formerly the Bureau of Cannabis Control, originally established as Bureau of Marijuana Control under Proposition 64, [1] [2] formerly the Bureau of Medical Marijuana Regulation [3] [4]) is an agency of the State of California within the Department of Consumer Affairs, charged with regulating medical cannabis (MMJ) in accordance with state law pursuant to the ...
A senior official at the US Department of Health and Human Services has called for easing restrictions on marijuana by reclassifying it as a Schedule III substance in a letter to the Drug ...